Immunological Hallmarks of JC Virus Replication in Multiple Sclerosis Patients on Long-Term Natalizumab Therapy-Reference-Cited by-同舟云学术

Immunological Hallmarks of JC Virus Replication in Multiple Sclerosis Patients on Long-Term Natalizumab Therapy

Published:2013-03-20 Issue:10 Volume:87 Page:6055-6059
ISSN:0022-538X
Container-title:Journal of Virology
language:en
Short-container-title:Journal of Virology

Author:

Hendel-Chavez H.,de Goer de Herve M.-G.,Giannesini C.,Mazet A.-A.,Papeix C.,Louapre C.,Chardain A.,Boutarfa N.,Theaudin M.,Adams D.,Gasnault J.,Stankoff B.,Taoufik Y.

Publisher

American Society for Microbiology

Subject

Virology,Insect Science,Immunology,Microbiology

Reference25 articles.

1. Progressive multifocal leukoencephalopathy and other forms of JC virus disease;Brew;Nat. Rev. Neurol,2010

2. New trends in progressive multifocal leukoencephalopathy;Gasnault;Rev. Neurol. (Paris),2006

3. Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases;Clifford;Lancet Neurol,2010

4. Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis;Kleinschmidt-DeMasters;N. Engl. J. Med,2005

5. Progressive multifocal leukoencephalopathy in a patient treated with natalizumab;Langer-Gould;N. Engl. J. Med,2005

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Frequent detection of IFN-gamma -producing memory effector and effector T cells in patients with progressive multifocal leukoencephalopathy;Frontiers in Immunology;2024-07-17

2. Chromosomal and gonadal factors regulate microglial sex effects in the aging brain;Brain Research Bulletin;2023-04

3. High effector-memory CD8+ T-cell levels correlate with high PML risk in natalizumab-treated patients;Multiple Sclerosis and Related Disorders;2020-11

4. Progressive multifocal leukoencephalopathy on dimethyl fumarate with preserved lymphocyte count but deep T-cells exhaustion;Multiple Sclerosis Journal;2020-07-20

5. Natalizumab related progressive multifocal leukoencephalopathy;Drug Discovery Today: Disease Models;2020